본문 바로가기
Evidentic

[Evidentic] Daratumumab

by 래빗랩스(RabbitLabs) 2021. 10. 14.

[Evidentic] Daratumumab

GHS0702

  • Product Concentration
  • 20 mg/mL
  • Volume per vial
  • 100 µL
  • Quantity per vial
  • 2 mg
  • Batch Number
  • GHS0702
  • Storage Temperature
  • -80°C

Target

CD38

Class of molecule

Monoclonal Antibody

Isotype

IgG1 kappa - Fully human

Host cells

Chinese Hamster Ovary (CHO) cells

Prepared from (Reference drug)​

Darzalex®

Therapeutic Area

Immuno-oncology

Therapeutic Indications

Multiple Myeloma

Mechanism of Action (MoA)

Utilises multiple effector functions ADCC, ADCP and CDC, resulting in immune mediated tumour cell death.

Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.

'Evidentic' 카테고리의 다른 글

[Evidentic] Adalimumab  (0) 2023.04.27
[Evidentic] Alemtuzumab  (0) 2022.09.26
[Evidentic] Bevacizumab  (0) 2022.08.16
[Evidentic] Adalimumab  (0) 2022.05.25
[Evidentic] Adalimumab  (0) 2022.04.25